-
Mashup Score: 0
An advanced algorithm was trained to evaluate more than 100 different details about the inside of a patient’s eye. Its ability to identify high-risk patients was comparable to more traditional techniques, exciting researchers.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
BAV patients are often excluded from TAVR trials, creating uncertainty about the best way to treat that population when aortic valve replacement is required. To learn more, researchers tracked CMS data from 2018 to 2022, presenting their findings in The Annals of Thoracic Surgery.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
#SAVR is linked to better long-term outcomes than #TAVR when treating patients w/ bicuspid aortic valves, according to a new study. https://t.co/JXZHiAjX57 @CardioBusiness
-
-
Mashup Score: 5FDA announces another recall for surgical devices over safety concerns—7 new injuries reported - 9 day(s) ago
Maquet Cardiovascular, a subsidiary of Getinge, is recalling two of its endoscopic vessel harvesting devices due to issues with different pieces bending, peeling or detaching during use. Some of the company’s other EVH devices were recently involved in a separate recall for similar reasons.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
FDA announces another #recall for surgical devices over safety concerns—7 new injuries reported #cardiology #surgery https://t.co/uBtEBYa6q5
-
-
Mashup Score: 1Exploring the 'new era' of HFpEF treatment: More options exist, but challenges remain - 9 day(s) ago
Clyde Yancy, MD, spoke with Cardiovascular Business about how the treatment of heart failure with preserved ejection fraction (HFpEF) has evolved in recent years.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Video - Clyde Yancy, MD, chief of cardiology, Northwestern, explains the latest science on treating HFpEF. @NMHheartdoc #HFpEF #heartfailure #cardiology https://t.co/OW9yIEFuaU
-
-
Mashup Score: 1Momentum continues for renal denervation as CMS considers national Medicare coverage - 10 day(s) ago
CMS is accepting public comments on the topic for a period of 30 days. Recor Medical and Medtronic have both shared statements in support of the potential policy shift.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Momentum continues for renal denervation as CMS considers national Medicare coverage @ReCorMedical @MedtronicCRDN #cardiology https://t.co/EMllsYuoeo
-
-
Mashup Score: 6
The center’s 2024 total of 174 heart transplants represents an increase of 36% compared to 2023, and 10 of the patients receiving a new heart were young children.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
‘A team effort’: VUMC sets world record for heart transplants in a single year @VUMChealth @VUMCDiscoveries #cardiology https://t.co/9nSBhGt02J
-
-
Mashup Score: 02025 Shockwave IVL Reimbursement Overview - 10 day(s) ago
Join us on Jan. 29th! Listen in to this webinar to gain a deeper understanding of how the technology of intravascular lithotripsy (IVL) works in order to code appropriately for peripheral and coronary IVL procedures. We’ll dig into coding and billing specifics for hospitals, ambulatory surgery centers and physicians across all payor types. Make sure your team is aware of all the coding rules and updates for 2025. Plus our expert panel will answer your questions live!
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
🚨 Upcoming Webinar on Jan. 29th! Discover how enterprise imaging is transforming cardiology and care teams: ✔️ Streamline patient data and imaging. ✔️ Enhance decision-making and efficiency. ✔️ Leverage AI for better outcomes. Register below https://t.co/aFl50wnS7w
-
-
Mashup Score: 0Medtronic expands carotid portfolio with Contego Medical deal - 10 day(s) ago
Medtronic entered into an exclusive U.S. distribution agreement with Contego Medical for carotid and peripheral vascular disease revascularization products. The agreement includes an option to acquire the full company at a later date.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Medtronic entered an exclusive U.S. distribution agreement with Contego for carotid and peripheral revascularization products. #Carotid #Stroke https://t.co/QOdnNJS1MK
-
-
Mashup Score: 1Why electrophysiologists needed a champion in Washington - 11 day(s) ago
Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu,” he said.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
Video - Heart Rhythm Society President Ken Ellenbogen, explains efforts to create new advocacy arm of HRS in Washington.#Cardiology #EPeeps @KennethEllenbo1 @HRSonline https://t.co/vrQTNwTCYr
-
-
Mashup Score: 0FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported - 11 day(s) ago
Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet-
FDA announces #recall after Philips heart monitors failed to send alerts—multiple deaths reported #cardiology #EPeeps https://t.co/kVT0VibJym
-
#AI uncovers ‘vascular fingerprints’ in the eye that predict #stroke risk #cardiology #deeplearning https://t.co/hP6r0rQzwm